<?xml version="1.0" encoding="UTF-8"?>

<wo-patent-document lang="en" status="Filed" country="MY">
  <wo-bibliographic-data status="Under Preliminary Examination">
    <application-reference>
      <document-id>
        <country>MY</country>
        <doc-number>PI2025006356</doc-number>
        <date>20251014</date>
      </document-id>
    </application-reference>
    <priority-claims>
      <priority-claim sequence="0001" kind="national">
        <country>US</country>
        <doc-number>63/251,469</doc-number>
        <date>20211001</date>
      </priority-claim>
      <priority-claim sequence="0002" kind="national">
        <country>US</country>
        <doc-number>63/339,597</doc-number>
        <date>20220509</date>
      </priority-claim>
      <priority-claim sequence="0003" kind="national">
        <country>US</country>
        <doc-number>63/402,835</doc-number>
        <date>20220831</date>
      </priority-claim>
    </priority-claims>
    <parties>
      <applicants>
        <applicant sequence="0001" app-type="applicant" designation="all">
          <addressbook lang="en">
            <name>XINTHERA, INC.</name>
            <address>
              <address-1>c/o Gilead Sciences, Inc. 333 Lakeside Drive Foster City, California 94404</address-1>
              <country>US</country>
            </address>
          </addressbook>
          <nationality>
            <country/>
          </nationality>
          <residence>
            <country>US</country>
          </residence>
        </applicant>
      </applicants>
      <inventors>
        <inventor sequence="0001">
          <addressbook lang="en">
            <name>HOFFMAN, Robert L.</name>
            <address>
              <address-1>10417 Avenida Magnifica San Diego, California 92131</address-1>
              <country>US</country>
            </address>
          </addressbook>
        </inventor>
        <inventor sequence="0002">
          <addressbook lang="en">
            <name>DONG, Qing</name>
            <address>
              <address-1>6147 Sagebrush Bend Way San Diego, California 92130</address-1>
              <country>US</country>
            </address>
          </addressbook>
        </inventor>
        <inventor sequence="0003">
          <addressbook lang="en">
            <name>VA, Porino Jinjo</name>
            <address>
              <address-1>14389 Bourgeois Way San Diego, California 92129</address-1>
              <country>US</country>
            </address>
          </addressbook>
        </inventor>
        <inventor sequence="0004">
          <addressbook lang="en">
            <name>KALDOR, Stephen W. (deceased)</name>
            <address>
              <address-1>c/o Gilead Sciences, Inc. 333 Lakeside Drive Foster City, California 94404</address-1>
              <country>US</country>
            </address>
          </addressbook>
        </inventor>
        <inventor sequence="0005">
          <addressbook lang="en">
            <name>TRZOSS, Lynnie</name>
            <address>
              <address-1>9120 Meadowrun Way San Diego, California 92129</address-1>
              <country>US</country>
            </address>
          </addressbook>
        </inventor>
      </inventors>
      <agents>
        <agent sequence="0001" rep-type="agent">
          <addressbook lang="en">
            <name>DEBORAH SYBIL DAVID</name>
            <address>
              <address-1>C/O DCC ADVANZ MALAYSIA SDN BHD, SUITE 609, BLOCK D, PHILEO DAMANSARA 1, NO. 9, JALAN 16/11, 46350 Petaling Jaya</address-1>
              <country>MY</country>
            </address>
          </addressbook>
        </agent>
      </agents>
    </parties>
    <invention-title lang="en">AZETIDINE AND PYRROLIDINE PARP1 INHIBITORS AND USES THEREOF</invention-title>
    <wo-national-office-event national-office-event-type="OPI" event-name="Open for public inspection">
      <wo-national-office-event-date>
        <date>20230401</date>
      </wo-national-office-event-date>
    </wo-national-office-event>
    <wo-national-office-event national-office-event-type="Filed" doc-number="PI2025006356" event-name="Filing">
      <wo-national-office-event-date>
        <date>20251014</date>
      </wo-national-office-event-date>
    </wo-national-office-event>
    <wo-national-office-filing-data appl-type="National Patent" file-type="">
      <kind-of-protection></kind-of-protection>
    </wo-national-office-filing-data>
  </wo-bibliographic-data>
  <abstract lang="en">
    <p num="0001">Described herein are azetidine and pyrrolidine PARP1 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of cancer.</p>
  </abstract>
</wo-patent-document>
